CD19 and B-cell non-Hodgkin lymphoma: For B-cell lymphoma and leukemia, Oelsner et al. engineered NK-92 cell line cells by lentiviral gene transfer to express CD19 CARs (CD3 ζ, CD28-CD3 ζ or CD137-CD3 ζ).